PubRank

L Cote

Author PubWeight™ 47.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology 2012 2.26
2 Accuracy of family history data on Parkinson's disease. Neurology 2003 2.15
3 The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003 2.11
4 Correlates of functional disability in essential tremor. Mov Disord 2001 1.72
5 Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology 2010 1.57
6 The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology 1994 1.54
7 Progression of parkinsonian signs in Parkinson disease. Arch Neurol 1999 1.53
8 The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995 1.51
9 Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology 1999 1.48
10 Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 1994 1.46
11 Fibrillary astrocytes proliferate in response to brain injury: a study combining immunoperoxidase technique for glial fibrillary acidic protein and radioautography of tritiated thymidine. Dev Biol 1979 1.37
12 An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 1988 1.33
13 Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 1986 1.20
14 Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol 1995 1.17
15 Altered serotonin metabolism in depressed patients with parkinson's disease. Neurology 1984 1.16
16 Normal pressure hydrocephalus and Parkinson's disease. J Neural Transm Suppl 1983 1.16
17 Altered systemic iron metabolism in Parkinson's disease. Neurology 1997 1.11
18 Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurol 1996 1.11
19 Mortality from Parkinson disease. Arch Neurol 1997 1.09
20 Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology 2003 1.09
21 Exflagellation of malarial parasites in human peripheral blood. J Clin Microbiol 1981 0.98
22 An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology 1990 0.96
23 Dietary iron, animal fats, and risk of Parkinson's disease. Mov Disord 1998 0.96
24 Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology 1998 0.94
25 Reliability of symptom onset assessment in Parkinson's disease. Mov Disord 1994 0.93
26 Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 1998 0.92
27 Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology 1987 0.90
28 Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease. N Engl J Med 1985 0.88
29 Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Ann Neurol 1993 0.87
30 Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Adv Neurol 1993 0.83
31 Prevalence of a history of shaking in persons 65 years of age and older: diagnostic and functional correlates. Mov Disord 1996 0.82
32 Depression in Parkinson's disease: a biochemical model. J Neuropsychiatry Clin Neurosci 1990 0.82
33 Depression and Parkinson's disease. Adv Neurol 1987 0.81
34 Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Arch Fam Med 1997 0.81
35 Pergolide therapy for Parkinson's disease: neurobehavioral changes. Neurology 1984 0.80
36 The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism Relat Disord 2011 0.80
37 Analysis of deaths in Parkinson patients on long-term levodopa therapy. Trans Am Neurol Assoc 1970 0.80
38 Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch Neurol 1992 0.79
39 Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis. Neurology 1991 0.78
40 A pilot study of risk factors for dementia in Parkinson's disease. Mov Disord 1990 0.78
41 Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism. One-year follow-up. Arch Neurol 1991 0.76
42 Systemic iron metabolism and mortality from Parkinson's disease. Neurology 1998 0.76
43 Platelet monoamine oxidase activity in affective disorder. Biol Psychiatry 1980 0.75
44 Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours. Int J Neurosci 2011 0.75
45 Regional and subcellular distribution of tyrosine hydroxylase. Neurology 1968 0.75
46 Clinical studies in controlled alcohol withdrawal syndrome. Concepts, design and assessment. Prog Neuropsychopharmacol Biol Psychiatry 1982 0.75